Protara Therapeutics, Inc. (TARA)
2.33
-0.11
(-4.51%)
USD |
NASDAQ |
Oct 23, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Price : 2.33 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.39 | 2.47 | 2.28 | 2.33 | 867582.0 |
| Oct 22, 2026 | 2.47 | 2.525 | 2.42 | 2.44 | 1.762M |
| Oct 21, 2026 | 2.57 | 2.61 | 2.49 | 2.50 | 971159.0 |
| Oct 20, 2026 | 2.34 | 2.575 | 2.33 | 2.56 | 1.501M |
| Oct 19, 2026 | 2.35 | 2.43 | 2.295 | 2.33 | 1.178M |
| Oct 16, 2026 | 2.38 | 2.465 | 2.32 | 2.32 | 1.165M |
| Oct 15, 2026 | 2.51 | 2.558 | 2.375 | 2.40 | 861832.0 |
| Oct 14, 2026 | 2.60 | 2.659 | 2.47 | 2.48 | 705524.0 |
| Oct 13, 2026 | 2.77 | 2.83 | 2.615 | 2.62 | 930392.0 |
| Oct 12, 2026 | 2.75 | 2.79 | 2.705 | 2.77 | 1.081M |
| Oct 09, 2026 | 2.69 | 2.785 | 2.65 | 2.755 | 1.037M |
| Oct 08, 2026 | 2.59 | 2.69 | 2.515 | 2.65 | 1.215M |
| Oct 07, 2026 | 2.54 | 2.67 | 2.51 | 2.59 | 731351.0 |
| Oct 06, 2026 | 2.63 | 2.70 | 2.53 | 2.555 | 803564.0 |
| Oct 05, 2026 | 2.71 | 2.72 | 2.565 | 2.63 | 1.398M |
| Oct 02, 2026 | 2.81 | 2.95 | 2.62 | 2.70 | 1.909M |
| Oct 01, 2026 | 3.06 | 3.10 | 2.745 | 2.76 | 4.999M |
| Sep 30, 2026 | 3.23 | 3.30 | 2.98 | 3.05 | 8.825M |
| Sep 29, 2026 | 3.33 | 3.345 | 3.21 | 3.21 | 391465.0 |
| Sep 28, 2026 | 3.27 | 3.386 | 3.19 | 3.25 | 431134.0 |
| Sep 25, 2026 | 3.35 | 3.44 | 3.23 | 3.28 | 552943.0 |
| Sep 24, 2026 | 3.54 | 3.55 | 3.315 | 3.35 | 661971.0 |
| Sep 23, 2026 | 3.69 | 3.75 | 3.44 | 3.54 | 882844.0 |
| Sep 22, 2026 | 3.55 | 3.88 | 3.55 | 3.68 | 2.893M |
| Sep 21, 2026 | 3.59 | 3.68 | 3.47 | 3.51 | 735465.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovelStem International Corp. | 0.0066 |
| Brainstorm Cell Therapeutics, Inc. | 0.8219 |
| Summit Therapeutics, Inc. | 15.47 |
| Kezar Life Sciences, Inc. | 7.29 |
| Clene, Inc. | 3.88 |
Price Related Metrics
| Price to Book Value | 0.8534 |
| Earnings Yield | -58.10% |
| Market Cap | 137.67M |